KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 71 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $385,200 | +7.0% | 40,000 | 0.0% | 0.33% | +21.5% |
Q2 2023 | $360,000 | +114549.7% | 40,000 | 0.0% | 0.27% | +9.8% |
Q1 2023 | $314 | +16.3% | 40,000 | 0.0% | 0.25% | +28.8% |
Q4 2022 | $270 | -100.0% | 40,000 | 0.0% | 0.19% | -53.2% |
Q3 2022 | $580,000 | +47.2% | 40,000 | 0.0% | 0.41% | +42.2% |
Q2 2022 | $394,000 | -33.2% | 40,000 | 0.0% | 0.29% | -32.5% |
Q1 2022 | $590,000 | +11.5% | 40,000 | 0.0% | 0.42% | +24.6% |
Q4 2021 | $529,000 | -24.2% | 40,000 | 0.0% | 0.34% | -28.2% |
Q3 2021 | $698,000 | -27.1% | 40,000 | 0.0% | 0.48% | -17.1% |
Q2 2021 | $958,000 | -6.8% | 40,000 | 0.0% | 0.57% | -6.1% |
Q1 2021 | $1,028,000 | +80.4% | 40,000 | +33.3% | 0.61% | +86.0% |
Q4 2020 | $570,000 | -24.6% | 30,000 | -50.0% | 0.33% | +29.6% |
Q3 2020 | $756,000 | +108.3% | 60,000 | +100.0% | 0.25% | +15.5% |
Q2 2020 | $363,000 | +57.8% | 30,000 | 0.0% | 0.22% | +7.4% |
Q1 2020 | $230,000 | -56.9% | 30,000 | 0.0% | 0.20% | -47.4% |
Q4 2019 | $534,000 | +53.4% | 30,000 | 0.0% | 0.39% | +67.2% |
Q3 2019 | $348,000 | – | 30,000 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |